Article Text
Abstract
This essay considers whether permitting the cost-effectiveness of healthcare to govern its allocation is ethically objectionable on the grounds that it fails to give sufficient weight to the severity of people’s health states. After documenting the popular sentiment that appears to support this criticism, the essay considers how to implement prioritising severity, focusing on Erik Nord’s work. The remainder of the essay scrutinises the ethical arguments supporting policies prioritising severity and challenges those who would prioritise severity to define a notion of severity whose prioritisation they can defend.
- health economics
- philosophy of medicine
- public policy
- healthcare economics
- public health ethics
Statistics from Altmetric.com
Footnotes
Contributors This essay is solely my own work.
Funding This research was done largely as a Ludwig Lachmann Fellow at the London School of Economics and Political Science, and I am grateful both for the funding and for the wonderful working environment in the Center for the Philosophy of the Natural and Social Sciences.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Patient consent for publication Not required.
Read the full text or download the PDF:
Other content recommended for you
- Pandemic prioritarianism
- Prioritarian principles for digital health in low resource settings
- Against lifetime QALY prioritarianism
- A note on Brock: prioritarianism, egalitarianism and the distribution of life years
- Pandemic justice: fairness, social inequality and COVID-19 healthcare priority-setting
- Genes and equality
- A framework for luck egalitarianism in health and healthcare
- Genetic information, insurance and a pluralistic approach to justice
- Public versus patient health preferences: protocol for a study to elicit EQ-5D-5L health state valuations for patients who have survived a stay in intensive care
- Developing a preference-based measure for weight-specific health-related quality of life in adolescence: the WAItE UK valuation study protocol